U.S. Government Sues Teva Pharmaceutical for Alleged Drug Kickbacks
Shares of Teva Pharmaceutical Industries (NYSE: TEVA) took a nearly 10% hit on Tuesday following news that the U.S. government is suing two of the company's business units.
In its official statement on the lawsuit, the Department of Justice alleges that Teva Pharmaceutical and Teva Neuroscience "illegally paid the Medicare copays for their multiple sclerosis product, Copaxone, through purportedly independent foundations that the companies used as conduits."
Source Fool.com